Interacting Drugs |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs Mefloquine |
Security Level |
 |
Mechanism |
Mefloquine: May diminish the therapeutic effect of Anticonvulsants. Mefloquine may decrease the serum concentration of Anticonvulsants. |
Management |
Mefloquine is contraindicated for malaria prophylaxis in persons with a history of convulsions. Monitor anticonvulsant concentrations and treatment response closely with concurrent use. |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs Mefloquine
Post Review about Hyoscyamine, atropine, scopolamine, and phenobarbital vs Mefloquine Click here to cancel reply.
Other Interactions of Hyoscyamine, atropine, scopolamine, and phenobarbital
Other Interactions of Mefloquine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.